Genome Medicine

Genetic data improve models predicting cognitive decline

Models combined genetic information with brain scans, using 23,997 UK Biobank participants for development and 3,000 people from two other studies for validation.

Paper by Mohammed Janahi, Luigi Lorenzini, Neil P. Oxtoby, +4 more authorsAlzheimer’s Disease Neuroimaging Initiative · Sidra Medical and Research Center · University College London

Our read

Biomarkers
Studied:
Cohort study of 3,000 older adults, against models without genetics
What changed:
Adding polygenic scores to hippocampal normative models improved prediction of cognitive scores longitudinally, outperforming models without genetics
The catch:
Hippocampal volume remains among the least reliable subcortical volume estimates due to shape and location

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

Data from 23,997 UK Biobank participants who reported British backgrounds supported an observational modeling study of cognitive decline—worsening memory and thinking. Researchers estimated the expected volume of the hippocampus, a brain region involved in memory, using age, sex and the space inside the skull. They added genetic scores that combined information about DNA variants linked to hippocampal volume.

The team tested the models in 1,245 participants from the Alzheimer's Disease Neuroimaging Initiative and 1,755 from the European Prevention of Alzheimer's Disease study. Adding genetic information strengthened associations with current cognitive test scores in both groups. It also improved prediction of future decline in the Alzheimer's Disease Neuroimaging Initiative group. The European Prevention of Alzheimer's Disease group showed no significant associations with cognitive changes over time.

Why it matters

For age-related neurodegenerative diseases, better forecasts of cognitive decline may help guide early intervention strategies, as the authors suggest.

Caveats

The analysis tested predictions, not whether model-guided care improved people's outcomes. Training excluded participants with several health conditions, and both training and validation applied ancestry restrictions, limiting application to other populations.

From the paper

Participants

In total, we included data from 23,997 participants, after applying exclusion criteria for existing health conditions and genetic ancestry.

Results, PGS at different thresholds contain complementary information

Limitation

Although we applied widely used harmonization techniques (such as imputation and NeuroComBat ), ideally acquisition and processing parameters should be closely matched to minimise confounding variance – though our approach mimics real world scenarios.

Discussion

Quoted word for word from the full text on PubMed Central.

Comments

Be the first to comment.